RankAlpha logo
Back to Rankings

BTAI

BioXcel TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
BTAI vs peer average
30/100
BTAI vs. peer average (F vs. D)
Grade spread
A 1 · B 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

HBIO is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $27.65M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerHBIOHarvard Bioscience
BTAI
BioXcel Therapeutics
HBIO
Harvard Bioscience
Grade
F
B
Momentum
10
94
Value
41
63
Sentiment
-
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs HBIO

BTAI / HBIO
Grade Position
Below peers
BTAI vs. peer average (F vs. D)
30/100
Momentum
10
HBIO
Value
41
HBIO
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BTAI
1
HBIO
Harvard Bioscience Inc Common
B
80/100
-3
2
PSTV
Plus Therapeutics Inc Common
F
20/100
Even
3
QCLS
Q/C Technologies Inc Common
F
20/100
Even
4
QUCY
Quantum Cyber NV Common
F
20/100
Even
5
TVRD
Tvardi Therapeutics Inc Common
F
20/100
Even
HBIO is the first peer returned for this comparison set.